Query author contributions in Reactome
Reactome depends on collaboration between our curation team and outside experts to
assemble and peer-review its pathway modules. The integration of ORCID within Reactome
enables us to meet a key challenge with authoring, curating and reviewing biological
information by incentivizing and crediting the external experts that contribute their
expertise and time to the Reactome curation process. More information is available at
ORCID and Reactome.
If you have an ORCID ID that is not listed on this page, please
forward this information to us and we will update your Reactome pathway records.
Details on Person FVIII C1, C2 domain variants [extracellular region]
| Class:Id | CandidateSet:9665831 |
| _displayName | FVIII C1, C2 domain variants [extracellular region] |
| _timestamp | 2019-12-06 01:35:22 |
| compartment | [Compartment:984] extracellular region |
| created | [InstanceEdit:9665826] Shamovsky, Veronica, 2019-11-01 |
| disease | [Disease:9661959] factor VIII deficiency |
| hasCandidate |
|
| hasMember |
|
| literatureReference | [LiteratureReference:9665814] Storage of factor VIII variants with impaired von Willebrand factor binding in Weibel-Palade bodies in endothelial cells [LiteratureReference:9665800] Deletion of alanine 2201 in the FVIII C2 domain results in mild hemophilia A by impairing FVIII binding to VWF and phospholipids and destroys a major FVIII antigenic determinant involved in inhibitor development [LiteratureReference:9665821] Surface-exposed hemophilic mutations across the factor VIII C2 domain have variable effects on stability and binding activities [LiteratureReference:9662340] A novel cause of mild/moderate hemophilia A: mutations scattered in the factor VIII C1 domain reduce factor VIII binding to von Willebrand factor [LiteratureReference:9665840] Mild hemophilia A patient with novel Pro1809Leu mutation develops an anti-C2 antibody inhibiting allogeneic but not autologous factor VIII activity [LiteratureReference:9665796] Some factor VIII (FVIII) inhibitors recognise a FVIII epitope(s) that is present only on FVIII-vWF complexes [LiteratureReference:9667091] A human antibody directed to the factor VIII C1 domain inhibits factor VIII cofactor activity and binding to von Willebrand factor [LiteratureReference:9665833] Hemophilic factor VIII C1- and C2-domain missense mutations and their modeling to the 1.5-angstrom human C2-domain crystal structure |
| modified | [InstanceEdit:9666379] Shamovsky, Veronica, 2019-11-05 [InstanceEdit:9667115] Shamovsky, Veronica, 2019-11-07 [InstanceEdit:9668160] Shamovsky, Veronica, 2019-11-19 [InstanceEdit:9670169] Shamovsky, Veronica, 2019-12-06 |
| name | FVIII C1, C2 domain variants F8 variants with mutations in the C1, C2 domains |
| species | [Species:48887] Homo sapiens |
| stableIdentifier | [StableIdentifier:9665853] R-HSA-9665831.1 |
| summation | [Summation:9666380] Set of F8 variants in HEMA patients that showed reduced bind... |
| (hasComponent) | [Complex:9665818] F8 C1,C2 domains variants [extracellular region] [Homo sapiens] |
|
[Change default viewing format]
|
No pathways have been reviewed or authored by FVIII C1, C2 domain variants [extracellular region] (9665831)